A proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK function

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager
	Reprints and Permissions
	Copyright Information
	Books from ASM Press
	MicrobeWorld

Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Catling, A. D.
	Articles by Weber, M. J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Catling, A. D.
	Articles by Weber, M. J.

Previous Article | Next Article

Mol. Cell. Biol., 10 1995, 5214-5225, Vol 15, No. 10
Copyright © 1995, American Society for Microbiology

A proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK function

AD Catling, HJ Schaeffer, CW Reuter, GR Reddy and MJ Weber
Department of Microbiology and Cancer Center, University of Virginia Health Sciences Center, Charlottesville 22908, USA.

Mammalian MEK1 and MEK2 contain a proline-rich (PR) sequence that is absent both from the yeast homologs Ste7 and Byr1 and from a recently cloned activator of the JNK/stress-activated protein kinases, SEK1/MKK4. Since this PR sequence occurs in MEKs that are regulated by Raf family enzymes but is missing from MEKs and SEKs activated independently of Raf, we sought to investigate the role of this sequence in MEK1 and MEK2 regulation and function. Deletion of the PR sequence from MEK1 blocked the ability of MEK1 to associate with members of the Raf family and markedly attenuated activation of the protein in vivo following growth factor stimulation. In addition, this sequence was necessary for efficient activation of MEK1 in vitro by B- Raf but dispensable for activation by a novel MEK1 activator which we have previously detected in fractionated fibroblast extracts. Furthermore, we found that a phosphorylation site within the PR sequence of MEK1 was required for sustained MEK1 activity in response to serum stimulation of quiescent fibroblasts. Consistent with this observation, we observed that MEK2, which lacks a phosphorylation site at the corresponding position, was activated only transiently following serum stimulation. Finally, we found that deletion of the PR sequence from a constitutively activated MEK1 mutant rendered the protein nontransforming in Rat1 fibroblasts. These observations indicate a critical role for the PR sequence in directing specific protein-protein interactions important for the activation, inactivation, and downstream functioning of the MEKs.

This article has been cited by other articles:

Skinner, S. J., Deleault, K. M., Fecteau, R., Brooks, S. A. (2008). Extracellular Signal-regulated Kinase Regulation of Tumor Necrosis Factor-{alpha} mRNA Nucleocytoplasmic Transport Requires TAP-NxT1 Binding and the AU-rich Element. J. Biol. Chem. 283: 3191-3199 [Abstract] [Full Text]
Skarpen, E., Flinder, L. I., Rosseland, C. M., Orstavik, S., Wierod, L., Oksvold, M. P., Skalhegg, B. S., Huitfeldt, H. S. (2008). MEK1 and MEK2 regulate distinct functions by sorting ERK2 to different intracellular compartments. FASEB J. 22: 466-476 [Abstract] [Full Text]
Ren, Y., Chen, Z., Chen, L., Woods, N. T., Reuther, G. W., Cheng, J. Q., Wang, H.-g., Wu, J. (2007). Shp2E76K Mutant Confers Cytokine-independent Survival of TF-1 Myeloid Cells by Up-regulating Bcl-XL. J. Biol. Chem. 282: 36463-36473 [Abstract] [Full Text]
Chrestensen, C. A., Eschenroeder, A., Ross, W. G., Ueda, T., Watanabe-Fukunaga, R., Fukunaga, R., Sturgill, T. W. (2007). Loss of MNK function sensitizes fibroblasts to serum-withdrawal induced apoptosis. GENES CELLS 12: 1133-1140 [Abstract] [Full Text]
Legewie, S., Schoeberl, B., Bluthgen, N., Herzel, H. (2007). Competing Docking Interactions can Bring About Bistability in the MAPK Cascade. Biophys. J 93: 2279-2288 [Abstract] [Full Text]
Casarez, E. V., Dunlap-Brown, M. E., Conaway, M. R., Amorino, G. P. (2007). Radiosensitization and Modulation of p44/42 Mitogen-Activated Protein Kinase by 2-Methoxyestradiol in Prostate Cancer Models. Cancer Res. 67: 8316-8324 [Abstract] [Full Text]
Lester, R. D., Jo, M., Montel, V., Takimoto, S., Gonias, S. L. (2007). uPAR induces epithelial mesenchymal transition in hypoxic breast cancer cells. J. Cell Biol. 178: 425-436 [Abstract] [Full Text]
Kumar, R., Manning, J., Spendlove, H. E., Kremmidiotis, G., McKirdy, R., Lee, J., Millband, D. N., Cheney, K. M., Stampfer, M. R., Dwivedi, P. P., Morris, H. A., Callen, D. F. (2006). ZNF652, A Novel Zinc Finger Protein, Interacts with the Putative Breast Tumor Suppressor CBFA2T3 to Repress Transcription. Mol Cancer Res 4: 655-665 [Abstract] [Full Text]
Bissonauth, V., Roy, S., Gravel, M., Guillemette, S., Charron, J. (2006). Requirement for Map2k1 (Mek1) in extra-embryonic ectoderm during placentogenesis. Development 133: 3429-3440 [Abstract] [Full Text]
Gioeli, D., Black, B. E., Gordon, V., Spencer, A., Kesler, C. T., Eblen, S. T., Paschal, B. M., Weber, M. J. (2006). Stress Kinase Signaling Regulates Androgen Receptor Phosphorylation, Transcription, and Localization. Mol. Endocrinol. 20: 503-515 [Abstract] [Full Text]
Rahmani, Z. (2006). APRO4 negatively regulates Src tyrosine kinase activity in PC12 cells. J. Cell Sci. 119: 646-658 [Abstract] [Full Text]
Lester, R. D., Jo, M., Campana, W. M., Gonias, S. L. (2005). Erythropoietin Promotes MCF-7 Breast Cancer Cell Migration by an ERK/Mitogen-activated Protein Kinase-dependent Pathway and Is Primarily Responsible for the Increase in Migration Observed in Hypoxia. J. Biol. Chem. 280: 39273-39277 [Abstract] [Full Text]
Tarrega, C., Rios, P., Cejudo-Marin, R., Blanco-Aparicio, C., van den Berk, L., Schepens, J., Hendriks, W., Tabernero, L., Pulido, R. (2005). ERK2 Shows a Restrictive and Locally Selective Mechanism of Recognition by Its Tyrosine Phosphatase Inactivators Not Shared by Its Activator MEK1. J. Biol. Chem. 280: 37885-37894 [Abstract] [Full Text]
Beeram, M., Patnaik, A., Rowinsky, E. K. (2005). Raf: A Strategic Target for Therapeutic Development Against Cancer. JCO 23: 6771-6790 [Abstract] [Full Text]
Kelly, P. A., Rahmani, Z. (2005). DYRK1A Enhances the Mitogen-activated Protein Kinase Cascade in PC12 Cells by Forming a Complex with Ras, B-Raf, and MEK1. Mol. Biol. Cell 16: 3562-3573 [Abstract] [Full Text]
Dangi, S., Shapiro, P. (2005). Cdc2-mediated Inhibition of Epidermal Growth Factor Activation of the Extracellular Signal-regulated Kinase Pathway during Mitosis. J. Biol. Chem. 280: 24524-24531 [Abstract] [Full Text]
Pullikuth, A., McKinnon, E., Schaeffer, H.-J., Catling, A. D. (2005). The MEK1 Scaffolding Protein MP1 Regulates Cell Spreading by Integrating PAK1 and Rho Signals. Mol. Cell. Biol. 25: 5119-5133 [Abstract] [Full Text]
Sullivan, D. E., Ferris, M., Pociask, D., Brody, A. R. (2005). Tumor Necrosis Factor-{alpha} Induces Transforming Growth Factor-{beta}1 Expression in Lung Fibroblasts Through the Extracellular Signal-Regulated Kinase Pathway. Am. J. Respir. Cell Mol. Bio. 32: 342-349 [Abstract] [Full Text]
Paccani, S. R., Tonello, F., Ghittoni, R., Natale, M., Muraro, L., D'Elios, M. M., Tang, W.-J., Montecucco, C., Baldari, C. T. (2005). Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. J. Exp. Med. 201: 325-331 [Abstract] [Full Text]
Chen, C., Sytkowski, A. J. (2004). Erythropoietin regulation of Raf-1 and MEK: evidence for a Ras-independent mechanism. Blood 104: 73-80 [Abstract] [Full Text]
Jiang, K., Sun, J., Cheng, J., Djeu, J. Y., Wei, S., Sebti, S. (2004). Akt Mediates Ras Downregulation of RhoB, a Suppressor of Transformation, Invasion, and Metastasis. Mol. Cell. Biol. 24: 5565-5576 [Abstract] [Full Text]
Lunin, V. V., Munger, C., Wagner, J., Ye, Z., Cygler, M., Sacher, M. (2004). The Structure of the MAPK Scaffold, MP1, Bound to Its Partner, p14: A COMPLEX WITH A CRITICAL ROLE IN ENDOSOMAL MAP KINASE SIGNALING. J. Biol. Chem. 279: 23422-23430 [Abstract] [Full Text]
Vomastek, T., Schaeffer, H.-J., Tarcsafalvi, A., Smolkin, M. E., Bissonette, E. A., Weber, M. J. (2004). Modular construction of a signaling scaffold: MORG1 interacts with components of the ERK cascade and links ERK signaling to specific agonists. Proc. Natl. Acad. Sci. USA 101: 6981-6986 [Abstract] [Full Text]
Eblen, S. T., Slack-Davis, J. K., Tarcsafalvi, A., Parsons, J. T., Weber, M. J., Catling, A. D. (2004). Mitogen-Activated Protein Kinase Feedback Phosphorylation Regulates MEK1 Complex Formation and Activation during Cellular Adhesion. Mol. Cell. Biol. 24: 2308-2317 [Abstract] [Full Text]
Slack-Davis, J. K., Eblen, S. T., Zecevic, M., Boerner, S. A., Tarcsafalvi, A., Diaz, H. B., Marshall, M. S., Weber, M. J., Parsons, J. T., Catling, A. D. (2003). PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation. J. Cell Biol. 162: 281-291 [Abstract] [Full Text]
Belanger, L.-F., Roy, S., Tremblay, M., Brott, B., Steff, A.-M., Mourad, W., Hugo, P., Erikson, R., Charron, J. (2003). Mek2 Is Dispensable for Mouse Growth and Development. Mol. Cell. Biol. 23: 4778-4787 [Abstract] [Full Text]
Sawhney, R. S., Sharma, B., Humphrey, L. E., Brattain, M. G. (2003). Integrin {alpha}2 and Extracellular Signal-regulated Kinase Are Functionally Linked in Highly Malignant Autocrine Transforming Growth Factor-{alpha}-driven Colon Cancer Cells. J. Biol. Chem. 278: 19861-19869 [Abstract] [Full Text]
Harding, A., Giles, N., Burgess, A., Hancock, J. F., Gabrielli, B. G. (2003). Mechanism of Mitosis-specific Activation of MEK1. J. Biol. Chem. 278: 16747-16754 [Abstract] [Full Text]
Sanz-Moreno, V., Casar, B., Crespo, P. (2003). p38{alpha} Isoform Mxi2 Binds to Extracellular Signal-Regulated Kinase 1 and 2 Mitogen-Activated Protein Kinase and Regulates Its Nuclear Activity by Sustaining Its Phosphorylation Levels. Mol. Cell. Biol. 23: 3079-3090 [Abstract] [Full Text]
Eblen, S. T., Kumar, N. V., Shah, K., Henderson, M. J., Watts, C. K. W., Shokat, K. M., Weber, M. J. (2003). Identification of Novel ERK2 Substrates through Use of an Engineered Kinase and ATP Analogs. J. Biol. Chem. 278: 14926-14935 [Abstract] [Full Text]
Chopra, A. P., Boone, S. A., Liang, X., Duesbery, N. S. (2003). Anthrax Lethal Factor Proteolysis and Inactivation of MAPK Kinase. J. Biol. Chem. 278: 9402-9406 [Abstract] [Full Text]
Gopalbhai, K., Jansen, G., Beauregard, G., Whiteway, M., Dumas, F., Wu, C., Meloche, S. (2003). Negative Regulation of MAPKK by Phosphorylation of a Conserved Serine Residue Equivalent to Ser212 of MEK1. J. Biol. Chem. 278: 8118-8125 [Abstract] [Full Text]
Delaney, A. M., Printen, J. A., Chen, H., Fauman, E. B., Dudley, D. T. (2002). Identification of a Novel Mitogen-Activated Protein Kinase Kinase Activation Domain Recognized by the Inhibitor PD 184352. Mol. Cell. Biol. 22: 7593-7602 [Abstract] [Full Text]
Varghese, J., Sade, H., Vandenabeele, P., Sarin, A. (2002). Head Involution Defective (Hid)-triggered Apoptosis Requires Caspase-8 but Not FADD (Fas-associated Death Domain) and Is Regulated by Erk in Mammalian Cells. J. Biol. Chem. 277: 35097-35104 [Abstract] [Full Text]
Eblen, S. T., Slack, J. K., Weber, M. J., Catling, A. D. (2002). Rac-PAK Signaling Stimulates Extracellular Signal-Regulated Kinase (ERK) Activation by Regulating Formation of MEK1-ERK Complexes. Mol. Cell. Biol. 22: 6023-6033 [Abstract] [Full Text]
Cunnick, J. M., Meng, S., Ren, Y., Desponts, C., Wang, H.-G., Djeu, J. Y., Wu, J. (2002). Regulation of the Mitogen-activated Protein Kinase Signaling Pathway by SHP2. J. Biol. Chem. 277: 9498-9504 [Abstract] [Full Text]
Kloth, M. T., Catling, A. D., Silva, C. M. (2002). Novel Activation of STAT5b in Response to Epidermal Growth Factor. J. Biol. Chem. 277: 8693-8701 [Abstract] [Full Text]
Sharma, P., Veeranna, , Sharma, M., Amin, N. D., Sihag, R. K., Grant, P., Ahn, N., Kulkarni, A. B., Pant, H. C. (2002). Phosphorylation of MEK1 by cdk5/p35 Down-regulates the Mitogen-activated Protein Kinase Pathway. J. Biol. Chem. 277: 528-534 [Abstract] [Full Text]
Cha, H., Lee, E. K., Shapiro, P. (2001). Identification of a C-terminal Region That Regulates Mitogen-activated Protein Kinase Kinase-1 Cytoplasmic Localization and ERK Activation. J. Biol. Chem. 276: 48494-48501 [Abstract] [Full Text]
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-e, Karandikar, M., Berman, K., Cobb, M. H. (2001). Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions. Endocr. Rev. 22: 153-183 [Abstract] [Full Text]
Eblen, S. T., Catling, A. D., Assanah, M. C., Weber, M. J. (2001). Biochemical and Biological Functions of the N-Terminal, Noncatalytic Domain of Extracellular Signal-Regulated Kinase 2. Mol. Cell. Biol. 21: 249-259 [Abstract] [Full Text]
JANOSCH, P., KIESER, A., EULITZ, M., LOVRIC, J., SAUER, G., REICHERT, M., GOUNARI, F., BÜSCHER, D., BACCARINI, M., MISCHAK, H., KOLCH, W. (2000). The Raf-1 kinase associates with vimentin kinases and regulates the structure of vimentin filaments. FASEB J. 14: 2008-2021 [Abstract] [Full Text]
Reuter, C. W. M., Morgan, M. A., Bergmann, L. (2000). Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?. Blood 96: 1655-1669 [Abstract] [Full Text]
Sheta, E. A., Harding, M. A., Conaway, M. R., Theodorescu, D. (2000). Focal Adhesion Kinase, Rap1, and Transcriptional Induction of Vascular Endothelial Growth Factor. JNCI J Natl Cancer Inst 92: 1065-1073 [Abstract] [Full Text]
Yeung, K., Janosch, P., McFerran, B., Rose, D. W., Mischak, H., Sedivy, J. M., Kolch, W. (2000). Mechanism of Suppression of the Raf/MEK/Extracellular Signal-Regulated Kinase Pathway by the Raf Kinase Inhibitor Protein. Mol. Cell. Biol. 20: 3079-3085 [Abstract] [Full Text]
Elorza, A., Sarnago, S., Mayor, F. Jr. (2000). Agonist-Dependent Modulation of G Protein-Coupled Receptor Kinase 2 by Mitogen-Activated Protein Kinases. Mol. Pharmacol. 57: 778-783 [Abstract] [Full Text]
MacNicol, M. C., Muslin, A. J., MacNicol, A. M. (2000). Disruption of the 14-3-3 Binding Site within the B-Raf Kinase Domain Uncouples Catalytic Activity from PC12 Cell Differentiation. J. Biol. Chem. 275: 3803-3809 [Abstract] [Full Text]
Nantel, A., Huber, M., Thomas, D. Y. (1999). Localization of Endogenous Grb10 to the Mitochondria and Its Interaction with the Mitochondrial-associated Raf-1 Pool. J. Biol. Chem. 274: 35719-35724 [Abstract] [Full Text]
Xu, B.-e, Wilsbacher, J. L., Collisson, T., Cobb, M. H. (1999). The N-terminal ERK-binding Site of MEK1 Is Required for Efficient Feedback Phosphorylation by ERK2 in Vitro and ERK Activation in Vivo. J. Biol. Chem. 274: 34029-34035 [Abstract] [Full Text]
Slack, J. K., Catling, A. D., Eblen, S. T., Weber, M. J., Parsons, J. T. (1999). c-Raf-mediated Inhibition of Epidermal Growth Factor-stimulated Cell Migration. J. Biol. Chem. 274: 27177-27184 [Abstract] [Full Text]
Nguyen, D. H.D., Catling, A. D., Webb, D. J., Sankovic, M., Walker, L. A., Somlyo, A. V., Weber, M. J., Gonias, S. L. (1999). Myosin Light Chain Kinase Functions Downstream of Ras/ERK to Promote Migration of Urokinase-type Plasminogen Activator-stimulated Cells in an Integrin-selective Manner. J. Cell Biol. 146: 149-164 [Abstract] [Full Text]
Schaeffer, H. J., Weber, M. J. (1999). Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers. Mol. Cell. Biol. 19: 2435-2444 [Full Text]
Sastry, S. K., Lakonishok, M., Wu, S., Truong, T. Q., Huttenlocher, A., Turner, C. E., Horwitz, A. F. (1999). Quantitative Changes in Integrin and Focal Adhesion Signaling Regulate Myoblast Cell Cycle Withdrawal. J. Cell Biol. 144: 1295-1309 [Abstract] [Full Text]
Xia, Y., Wu, Z., Su, B., Murray, B., Karin, M. (1998). JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension. Genes Dev. 12: 3369-3381 [Abstract] [Full Text]
Schaeffer, H. J., Catling, A. D., Eblen, S. T., Collier, L. S., Krauss, A., Weber, M. J. (1998). MP1: A MEK Binding Partner That Enhances Enzymatic Activation of the MAP Kinase Cascade. Science 281: 1668-1671 [Abstract] [Full Text]
Dang, A., Frost, J. A., Cobb, M. H. (1998). The MEK1 Proline-rich Insert Is Required for Efficient Activation of the Mitogen-activated Protein Kinases ERK1 and ERK2 in Mammalian Cells. J. Biol. Chem. 273: 19909-19913 [Abstract] [Full Text]
Silvy, M., Martin, P.-M., Chajry, N., Berthois, Y. (1998). Differential Dose-Dependent Effects of Epidermal Growth Factor on Gene Expression in A431 Cells: Evidence for a Signal Transduction Pathway That Can Bypass Raf-1 Activation. Endocrinology 139: 2382-2391 [Abstract] [Full Text]
Enslen, H., Raingeaud, J., Davis, R. J. (1998). Selective Activation of p38 Mitogen-activated Protein (MAP) Kinase Isoforms by the MAP Kinase Kinases MKK3 and MKK6. J. Biol. Chem. 273: 1741-1748 [Abstract] [Full Text]
Xu, S., Khoo, S., Dang, A., Witt, S., Do, V., Zhen, E., Schaefer, E. M., Cobb, M. H. (1997). Differential Regulation of Mitogen-Activated Protein/ERK Kinase (MEK)1 and MEK2 and Activation by a Ras-Independent Mechanism. Mol. Endocrinol. 11: 1618-1625 [Abstract] [Full Text]
Bjorkoy, G., Perander, M., Overvatn, A., Johansen, T. (1997). Reversion of Ras- and Phosphatidylcholine-hydrolyzing Phospholipase C-mediated Transformation of NIH 3T3 Cells by a Dominant Interfering Mutant of Protein Kinase C lambda Is Accompanied by the Loss of Constitutive Nuclear Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Activity. J. Biol. Chem. 272: 11557-11565 [Abstract] [Full Text]
Kasukabe, T., Okabe-Kado, J., Honma, Y. (1997). TRA1, a Novel mRNA Highly Expressed in Leukemogenic Mouse Monocytic Sublines But Not in Nonleukemogenic Sublines. Blood 89: 2975-2985 [Abstract] [Full Text]
Butch, E. R., Guan, K.-L. (1996). Characterization of ERK1 Activation Site Mutants and the Effect on Recognition by MEK1 and MEK2. J. Biol. Chem. 271: 4230-4235 [Abstract] [Full Text]
Pei, L. (2000). Activation of Mitogen-activated Protein Kinase Cascade Regulates Pituitary Tumor-transforming Gene Transactivation Function. J. Biol. Chem. 275: 31191-31198 [Abstract] [Full Text]
Yan, C., Luo, H., Lee, J.-D., Abe, J.-i., Berk, B. C. (2001). Molecular Cloning of Mouse ERK5/BMK1 Splice Variants and Characterization of ERK5 Functional Domains. J. Biol. Chem. 276: 10870-10878 [Abstract] [Full Text]
Sachdev, P., Jiang, Y.-X., Li, W., Miki, T., Maruta, H., Nur-e-Kamal, M. S. A., Wang, L.-H. (2001). Differential Requirement for Rho Family GTPases in an Oncogenic Insulin-like Growth Factor-I Receptor-induced Cell Transformation. J. Biol. Chem. 276: 26461-26471 [Abstract] [Full Text]
Matter, M. L., Ruoslahti, E. (2001). A Signaling Pathway from the alpha 5beta 1 and alpha vbeta 3 Integrins That Elevates bcl-2 Transcription. J. Biol. Chem. 276: 27757-27763 [Abstract] [Full Text]

J. Bacteriol.	J. Virol.	Eukaryot. Cell

Microbiol. Mol. Biol. Rev.	Clin. Vaccine Immunol.	All ASM Journals